Skip to main content
OpenTrials

Clinical trial condition

Mucopolysaccharidoses

Explore clinical trials studying Mucopolysaccharidoses. Study availability and eligibility vary by location and protocol.

39 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Mucopolysaccharidoses trial results

Active, not recruiting

A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT

NCT06149403

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • University of Minnesota, Pediatrics Minneapolis, Minnesota, United States
  • Ospedale San Raffaele Milan, Italy
  • Princess Maxima Center Utrecht, Netherlands
  • UMC Utrecht Utrecht, Netherlands
View Trial Details
Completed

Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VI

NCT01521429

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +8 more
Locations
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis

NCT04112602

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +8 more
Locations
  • Metabolic Disease Competence Centre - Medical Genetics Department - University Hospital, Angers Angers, France
  • Metabolic Disease Reference Centre - Medical Genetics Department - University Hospital, Bordeaux Bordeaux, France
  • Metabolic Disease Competence Centre - Medical Genetics Department - University Hospital, Brest Brest, France
  • Metabolic Disease Competence Centre - Pediatrics Department - University Hospital, Rennes Rennes, France
View Trial Details
Completed

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®

NCT00920647

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Birmingham Children's Hospital NHS Foundation Trust Birmingham, United Kingdom
View Trial Details

Related conditions